BOSTON (AP) - Federal prosecutors say drugmaker Pfizer Inc. has agreed to pay nearly $785 million to resolve allegations that one of its companies failed to give Medicaid the same discounts it provided to private purchasers of a heartburn treatment.
The deal reached tentatively in February and finalized on Wednesday centered on Wyeth's practices related to rebates on Protonix sales between 2001 and 2006.
Pfizer agrees to $785M settlement in drug discount case
Aucun commentaire:
Enregistrer un commentaire